Activity of type IV collagenases in benign and malignant breast disease
Authors:
- Dw MilesDMDw Miles
- Lc HapperfieldLHLc Happerfield
- M S NaylorMNM S Naylor
- Lg BobrowLBLg Bobrow
- Rd RubensRRRd Rubens
- Fr BalkwillFBFr Balkwill
Open Access
- 1 May 1993
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (5) , 1126-1131
Abstract
Using zymography and computer assisted image analysis, we have measured the levels of type IV collagenases in biopsies from normal breast, and benign and malignant breast disease. The 92 kDa form was present in three of 11 cases of normal/benign disease, three of nine grade I tumours, four of 12 grade II tumours, but 11 of 11 grade III tumours. Mean levels were higher in grade III tumours (P < 0.0001). When the levels of 72 kDa collagenase and its active 62 kDa form were considered together, there was no difference between the benign and malignant cases (P = 0.55), but the amount of active enzyme, considered as a proportion of the 62 + 72 kDa forms, was significantly higher in malignant disease (P = 0.003). There was also a trend towards a higher proportion of active enzyme with increasing tumour grade (P < 0.0001). In situ hybridisation and immunohistochemistry studies showed that that mRNA and protein for the 92 kDa enzyme was primarily found in the tumour stroma. mRNA for the 72 kDa enzyme was also found in stromal areas. This study demonstrates a clear relationship between production of Type IV collagenases and malignant breast disease. Inhibitors of these enzymes may be of value in preventing metastatic disease.Keywords
This publication has 31 references indexed in Scilit:
- Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Growth factors specifically alter hair follicle cell proliferation and collagenolytic activity alone or in combinationDifferentiation, 1990
- Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.Journal of Clinical Investigation, 1990
- Induction and stimulation of 92-kDa gelatinase / type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor αBiochemical and Biophysical Research Communications, 1990
- Secreted ProteasesAnnals of the New York Academy of Sciences, 1990
- Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotypeBiochemical and Biophysical Research Communications, 1988
- Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages.Journal of Clinical Investigation, 1987
- THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER*Anz Journal of Surgery, 1984
- Detergent-activation of latent collagenase and resolution of its component moleculesBiochemical and Biophysical Research Communications, 1982
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976